
Celebrating the Success of the ILC Symposium 2023!
Thank you for your enthusiastic participation in the ILC Symposium 2023. Your presence, diverse perspectives, and unwavering support played a pivotal role in making the symposium a resounding success. Our thanks to all researchers, patient advocates, and clinicians for their active involvement.
We were honored to have hosted 221 attendees in person and 51 virtually, creating a vibrant global exchange of knowledge. The symposium was enriched by the participation of individuals from 15 different countries, fostering a truly international dialogue.
Together, we’re advancing understanding of ILC, improving treatments, and enhancing support for those affected. We look forward to the positive outcomes and collaborations arising from this symposium.
With warm regards,
Organizing Committee ILC 2023
Watch the recorded sessions below
Thank you to the presenters who agreed to record and share their presentations. Not all presentations were recorded. Please contact the presenters directly with questions. For the complete agenda, click here.





Keynote Speakers

Swiss Federal Institute of Technology Lausanne (EFPL), Switzerland, Inst. of Cancer Research, London, UK

Dana-Farber Cancer Institute,
Boston, MA, USA
Speakers, Chairs, & Moderators

UPMC, Magee-Womens Hospital, Pittsburgh, PA, USA

University of Edinburgh, Scotland

European Institute of Oncology, University of Milan, Italy

University of Utah,
Salt Lake City, UT, USA

Weill Cornell Med./New York-Presbyterian Hosp., NY, USA

Fred Hutchinson Cancer Center, Seattle, WA, USA

UPMC Hillman Cancer Center
Pittsburgh, PA, USA

UMC Utrecht,
Netherlands

Katholieke Universiteit Leuven,
Leuven, Belgium

Katholieke Universiteit Leuven,
Leuven, Belgium

UPMC, Pittsburgh, PA, USA

Institut Curie, Paris, France

Hospital for Sick Children,
University of Toronto,
Toronto, ON

University of Pittsburgh, UPMC
Pittsburgh, PA, USA

Lobular Breast Cancer Ireland

Baylor College of Medicine,
Houston, TX, USA

University of Michigan, Ann Arbor, MI, USA

NSABP,
Pittsburgh, PA, USA

UPMC,
Pittsburgh, PA, USA

UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Independent Breast Cancer Advocate

University of Texas Southwestern,
Dallas, TX, USA

University of Pittsburgh, Pittsburgh, PA, USA

Penn Medicine, Philadelphia, PA, USA

Dana-Farber Cancer Institute,
Boston, MA, USA

Charité-Universitätsmedizin, Berlin, Germany

Dana-Farber Cancer Institute,
Boston, MA, USA

UMC Utrecht,
Netherlands

Independent Breast Cancer Advocate

Institute for Precision Medicine, University of Pittsburgh & UPMC, Pittsburgh, PA, USA

Fred Hutch Cancer Center, University of Washington, Seattle, WA, USA

UPMC, Harrisburg, PA, USA

Fred Hutchinson Cancer Center,
Seattle, WA, USA

Guiding Researchers & Advocates to Scientific Partnerships (GRASP)

University of Pittsburgh, UPMC
Pittsburgh, PA, USA

UPMC, Monroeville, PA, USA

Breast Cancer Advocate, Dynami Foundation

University of Texas MD Anderson Cancer Center,
Houston, TX, USA

University of California San Francisco, San Francisco, CA

UPMC Hillman Cancer Center; Magee-Womens Research Institute, Pittsburgh, PA, USA

Memorial Sloan Kettering Cancer Center,
New York, NY, USA

Independent ILC advocate; Breast Cancer Care & Research Fund (BCCRF)

The Ohio State, Columbus, OH, USA

Georgetown University,
Washington, DC, USA

Kings College London, London,
United Kingdom

UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA

UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA

University of Colorado Denver, Anschutz Medical Campus,
Denver, CO, USA

University of Queensland, Queensland, Australia

Foundation Medicine,
Boston, USA

Lobular Breast Cancer UK (LBCUK)

Hoag Family Cancer Institute, University of Southern, California, USA

Katholieke Universiteit Leuven,
Leuven, Belgium

University Hospitals Leuven,
Leuven, Belgium

Royal College of Surgeons in Ireland (RCSI),
Dublin, Ireland

Institut Curie, Paris, France

MBCI Advocate, MBC Alliance-Become Project

Independent Breast Cancer Advocate

Dwek Inst. for Cancer Therapy Research, Weizmann Institute of Science, Rehovot, Israel

RCSI, Dublin, Ireland
Agenda – Click here for PDF
Abstract Booklet – Click here for PDF
ILC 2023 Posters
The poster PDFs provided here have been shared with the consent of the authors. This collection includes poster PDFs for 29 out of 50 posters, depending on which authors granted permission for their poster PDFs to be published.
Travel Fellowship Awardees
We are thrilled to announce the distinguished recipients of the Travel Fellowship for the upcoming ILC Symposium 2023. These exceptional individuals have demonstrated outstanding dedication and contributions to the field of invasive lobular breast cancer research.
Awardees attending from within the USA will receive $800, while international attendees will receive $1200 in fellowship amounts. These fellowships aim to assist participants in covering their expenses and fostering a diverse and inclusive environment for knowledge exchange.
Join us in congratulating the following scholars who have been selected to receive the prestigious Travel Fellowship Award, listed below and here.

Their commitment and passion exemplify the spirit of collaboration and knowledge-sharing that the ILC Symposium stands for. We eagerly anticipate their participation and look forward to their valuable contributions at the symposium.
We extend our heartfelt appreciation to all applicants for their exceptional submissions and encourage everyone to be part of this inspiring event.
For Breast Cancer Advocates
CLICK HERE for the ILC Workshop Agenda.
Presentations from the Symposium
Digital Toolkit for Advocates
We are delighted to present the “Digital Toolkit for Advocates” designed exclusively for patient advocates attending the ILC Symposium 2023. This comprehensive toolkit is aimed at enhancing your symposium experience by providing valuable resources and empowering you in your advocacy journey.
Inside the toolkit, you’ll find a treasure trove of resources, including:
📽️ Video Recordings: Access video recordings of past symposium sessions to catch up on valuable insights shared by renowned experts in the field.
🎧 Instructive Recordings: Dive deeper into instructive sessions that offer valuable tips and advice on patient advocacy, communication, and empowerment.
🔗 Links to Advocacy Resources: Discover a curated collection of links to advocacy resources, including Facebook groups and other online platforms where you can connect with like-minded advocates.
💡 Useful Resources: Find a compilation of valuable resources, documents, and informative materials that can aid you in your advocacy efforts.
This Digital Toolkit is your companion throughout the symposium and beyond, offering a wealth of knowledge and support to enhance your advocacy journey. We hope these resources empower you to make a positive impact in the field of invasive lobular breast cancer research.
Click here to access the Digital Toolkit for Advocates
International Organizing Committee

Chair
Professor, Univ of Pittsburgh, Co-Director, Womens Cancer Resarch Center, Co-Leader Cancer Biology Program, UPMC HCC and MWRI

Professor of Experimental & Preclinical Oncology, University Medical Center Utrecht

Associate Professor of Clinical Medicine, University of Pennsylvania, Director of the Rena Rowan Breast Center at Abramson Cancer Center

Associate Professor of Surgery, University of California San Francisco, Principal Investigator of the Lobular Breast Cancer Research Program

Department Head of Pathology and Pole Coordinator of Pathology-Genomics and Immunology, Institut Curie

Assistant Professor of Oncology, KU Leuven, Head of the Laboratory for Translational Breast Cancer Research
Local Organizing Committee

Website and Media Manager
Senior Research Scientist, Institute for Precision Medicine, University of Pittsburgh/UPMC Hillman Cancer Center
Laughing Mantis Studio

Logistics Coordinator
University of Pittsburgh, UPMC Hillman Cancer Center

Symposium Director
Senior Research Scientist, University of Pittsburgh, UPMC Hillman Cancer Center

Administrator
University of Pittsburgh, UPMC Hillman Cancer Center

Director, Institute for Precision Medicine, Univ. of Pittsburgh and UPMC; Professor of Pharmacology & Chemical Biology and Human Genetics, Univ. of Pittsburgh, Women’s Cancer Research Center, UPMC Hillman Cancer Center; Magee-Womens Research Institute & Foundation

Assistant Professor of Surgery, University of Pittsburgh, UPMC Magee Womens Hospital, UPMC Hillman Cancer Center

Event Coordinator
Administrative Assistant, University of Pittsburgh, UPMC Hillman Cancer Center
ryann@upmc.edu

Social Activities Coordinator
University of Pittsburgh, UPMC Hillman Cancer Center
GlobMob (Patient Advocate) Organizing Committee

Co-chair
Independent ILC advocate (also: Breast Cancer Care & Research Fund BCCRF)

Co-chair
Lobular Breast Cancer UK (LBCUK)

Lobular Ireland

Independent advocate

Breast Cancer Research Advocacy Network (bcRAN)

Guiding Researchers & Advocates to Scientific Partnerships (GRASP)

Lobular Breast Cancer Alliance Inc.

Independent advocate (also: BCRF research campaign)

Independent ILC advocate (also: Metastatic Lobular Advocate, ILC Symposium FB page, LBCA Lead Research Advocate)

Independent ILC advocate (also: Cleveland Clinic Lobular Fund, and LBCA Research Advocate)

Fred Hutchinson Cancer Center,
Seattle, WA, USA;
Independent ILC advocate (Two ILC Science & Support FB groups/ILC Symp FB group w/Julia Katherine)

Guiding Researchers & Advocates to Scientific Partnerships (GRASP)

Canadian Breast Cancer Network (CBCN) Lobular Breast Cancer Ambassador

Independent Advocate, ILC and Founder, Dynami Foundation – (LBCA)

European Lobular Breast Cancer Consortium (ELBCC)

Individual MBCl advocate, MBC Alliance-BECOME project, LBBC

Independent advocate
Advisors

BCRF

Susan G. Komen
The Assembly
5051 Centre Avenue
Pittsburgh, PA 15213
A historical venue to create memories: The ILC symposium 2023 will be held at The Assembly building in Pittsburgh. This is a unique venue with a rich history unlike any other. A century ago, The Assembly was Ford automotive’s first Model T assembly plant in the US. Over the years the building has become a clothing store and a stationary store. Today, the building has been transformed into a cutting-edge research facility, housing researchers working on cancer and other diseases. We hope this venue will facilitate innovative ideas, new collaboration and relationships, and many priceless memories. Read more on the fascinating history of the venue here: The Assembly: A former Model T factory builds the next generation of cancer treatments.












Then and now


Sponsors
Platinum Level




Gold Level




Silver Level




















Bronze Level




Institutional Support







